id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-1445-0074,FDA,FDA-2013-D-1445,Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2020-10-05T04:00:00Z,2020,10,2020-10-05T04:00:00Z,,2024-11-06T23:40:06Z,,1,0,09000064848d3169
FDA-2013-D-1445-0073,FDA,FDA-2013-D-1445,Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2020-09-29T04:00:00Z,2020,9,2020-09-29T04:00:00Z,,2024-11-06T23:40:18Z,,1,0,090000648489b73e
FDA-2013-D-1445-0072,FDA,FDA-2013-D-1445,Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Guidance for Industry and  Food and Drug Administration Staff; Availability,Notice,Notice of Availability,2020-09-29T04:00:00Z,2020,9,2020-09-29T04:00:00Z,,2020-09-29T19:06:55Z,2020-21463,0,0,090000648489886d
FDA-2013-D-1445-0065,FDA,FDA-2013-D-1445,"Blood Glucose Monitoring Test Systems for Prescription Point-of-Care
Use; Draft Guidance for Industry and Food and Drug Administration Staff;
Availability",Notice,Notice of Availability,2018-11-30T05:00:00Z,2018,11,2018-11-30T05:00:00Z,2019-03-01T04:59:59Z,2024-11-12T22:50:38Z,2018-26034,1,0,0900006483916275
FDA-2013-D-1445-0066,FDA,FDA-2013-D-1445,Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use Draft Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2018-11-30T05:00:00Z,2018,11,2018-11-30T05:00:00Z,,2024-11-12T22:49:53Z,,1,0,09000064839196ea
FDA-2013-D-1445-0062,FDA,FDA-2013-D-1445,"Blood Glucose Monitoring Test Systems for Prescription Point-of-Care
Use; Guidance for Industry and Food and Drug Administration Staff;
Availability",Notice,Notice of Availability,2016-10-11T04:00:00Z,2016,10,2016-10-11T04:00:00Z,,2016-10-11T15:17:52Z,2016-24430,0,0,09000064822d1a6d
FDA-2013-D-1445-0063,FDA,FDA-2013-D-1445,Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2016-10-11T04:00:00Z,2016,10,2016-10-11T04:00:00Z,,2024-11-11T21:32:39Z,,1,0,09000064822dd986
FDA-2013-D-1445-0013,FDA,FDA-2013-D-1445,"Blood Glucose Monitoring Test Systems for Prescription Point-of-Care
Use; Draft Guidance for Industry and Food and Drug Administration Staff;
Extension of Comment Period",Notice,Extension of Comment Period,2014-04-09T04:00:00Z,2014,4,2014-04-09T04:00:00Z,2014-05-08T03:59:59Z,2014-05-09T01:02:01Z,2014-07898,0,0,09000064816ab265
FDA-2013-D-1445-0012,FDA,FDA-2013-D-1445,"Blood Glucose Monitoring Test Systems for Prescription Point-of-Care
Use; Draft Guidance for Industry and Food and Drug Administration Staff;
Extension of Comment Period",Notice,,2014-04-09T00:00:00Z,2014,4,,,2014-04-09T15:35:53Z,,0,1,09000064816ab3db
FDA-2013-D-1445-0002,FDA,FDA-2013-D-1445,"Blood Glucose Monitoring Test Systems for Prescription Point-of-Care
Use; Draft Guidance for Industry and Food and Drug Administration Staff",Other,Guidance,2014-01-08T05:00:00Z,2014,1,2014-01-08T05:00:00Z,,2024-11-07T23:01:39Z,,1,0,09000064814f47d7
FDA-2013-D-1445-0001,FDA,FDA-2013-D-1445,"Blood Glucose Monitoring Test Systems for Prescription Point-of-Care
Use; Draft Guidance for Industry and Food and Drug Administration Staff;
Availability",Notice,Notice of Availability,2014-01-07T05:00:00Z,2014,1,2014-01-07T05:00:00Z,2014-04-08T03:59:59Z,2014-07-01T17:05:55Z,2014-00023,0,0,09000064814f130a